Make tocilizumab, plasma therapy available for every Covid patient: Gehlot

Gehlot directed officials to ensure availability of plasma and life-saving injections as per requirement in all medical colleges and district hospitals of the state

Coronavirus
Health workers wearing PPE kit check the temperature, blood oxygen screening of a child for COVID-19 symptoms at a residential building at Adarsh Nagar area of Malad, in Mumbai on Saturday.
Press Trust of India Jaipur
2 min read Last Updated : Jul 27 2020 | 8:26 AM IST
Rajasthan Chief Minister Ashok Gehlot on Sunday directed officials to make available life-saving tocilizumab injection and plasma therapy to every Covid-19 patient in critical condition.

In a review meeting on the coronavirus situation in the state, he said that tocilizumab injection costs around Rs 40,000 and is out of reach for poor and the state government will immediately approve funds for making the drug available for all.

Gehlot directed officials to ensure availability of plasma and life-saving injections as per requirement in all medical colleges and district hospitals of the state along with the SMS hospital.

The Chief Minister directed to promote plasma therapy in the treatment of coronavirus and to organise a plasma donation camp across the state.

Those who have recovered from coronavirus should be encouraged to donate plasma keeping health protocol in mind, the chief minister said.

"Make such an arrangement that the plasma needed for therapy should be present in our bank. For this, awareness campaigns and donation camps should be set up," Gehlot said.

It was informed in the meeting that plasma therapy has started in Jaipur, Jodhpur and Kota.

Gehlot said that the state government has increased Covid-19 testing capacity and there should not be no delay in getting test results.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsAshok GehlotRajasthan government

Next Story